Bayer's primary areas of business include human and veterinary pharmaceuticals; consumer healthcare products; agricultural chemicals and biotechnology products; and high value polymers. Now we will invest further in inclusive growth to enable positive development for more people.To this end, we have established clear targets up to 2030 for our core issues of It is implemented operationally with the aid of nonfinancial targets and key performance indicators (KPIs) which we will pursue with the same rigor as our financial targets.